Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
ARQT
ARQT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
Latest ARQT ETF News Today | Earnings, Events & Price Alerts
ARQT News
Arcutis to Present at TD Cowen Health Care Conference in Boston
3d ago
Yahoo Finance
Arcutis (ARQT) Q4 2025 Earnings Call Transcript
5d ago
NASDAQ.COM
Arcutis Biotherapeutics Q4 Earnings Exceed Expectations
5d ago
seekingalpha
Max Homa Shares Journey with Seborrheic Dermatitis
Feb 24 2026
Newsfilter
Arcutis and Take-Two Options Trading Activity Surges
Feb 19 2026
NASDAQ.COM
Tejara Capital Fully Exits Arcutis Biotherapeutics Stake
Feb 06 2026
Fool
Arcutis' ZORYVE Revenue Reaches $244.6M in 2025 YTD, Anticipates $470M for 2026
Jan 06 2026
NASDAQ.COM
Sprott Silver Miners ETF Declines 2.3% with Americas Gold and Vizsla Silver Underperforming
Dec 31 2025
NASDAQ.COM
Suvretta Capital Reduces Arcutis Stake by $35.78 Million
Dec 23 2025
Fool
Suvretta Capital Management Sells Nearly 1.1M ARQT Shares, Reducing Position by $35.78M
Dec 23 2025
NASDAQ.COM
Zacks Industry Forecast for Arcutis, Amicus, and ANI
Dec 18 2025
NASDAQ.COM
5 Biotech Stocks to Keep an Eye On for Possible Growth
Dec 17 2025
NASDAQ.COM
Evaluating Arcutis Biotherapeutics Following a 99% Year-to-Date Increase and Varied Valuation Indicators
Dec 14 2025
Yahoo Finance
This Biotech Stock Might Alleviate Your Portfolio's Struggles
Dec 14 2025
NASDAQ.COM
Reasons to Consider Arcutis Biotherapeutics, Inc. (ARQT) as a Strong Momentum Stock: Is It Time to Buy?
Dec 10 2025
NASDAQ.COM
Arcutis Appoints Amit Munshi to Board, Strengthening Leadership for Growth
Dec 08 2025
Globenewswire
Show More News
